Keywords
captopril
pharmaceutical formulations
How to Cite
Abstract
A simple, precise, rapid and low-cost potentiometric method for captopril determination in pureform and in pharmaceutical preparations is proposed. Captopril present in tablets containing known
quantity of drug was potentiometrically titrated in aqueous solution with NaOH using a glass pH elec-
trode, coupled to an autotitrator. No interferences were observed in the presence of common compo-
nents of the tablets as lactose, microcrystalline cellulose, croscarmellose sodium, starch and magnesium
stearate. The analytical results obtained by applying the proposed method compared very favorably with
those obtained by the United States Pharmacopoeia Standard procedure. Recovery of captopril from
various tablet dosage formulations range from 98.0 to 102.0%.
References
ASHOUR, F. M.; SALAMA, F. M.; AZIZA, M. A. E. A
colorimetric method for the determination of captopril. J.
Drugs Res., v. 19, n. 1-2, p. 323-326, 1990.
ASKAL, H. F. New spectrophotometric methods for
determination of captopril bulk drug and tablets. Talanta, v. 10, p. 1155-1158, 1991.
BALD, E.; SYPNIEWSKI, S. Determination of thiol
drugs in pharmaceutical formulations as their 5-pyridinium
derivatives by high-performance liquid chromatography
with ultraviolet detection. Fresenius J. Anal. Chem., v.
, n. 4, p. 554-555, 1997.
CAVRINI, V.; GATTI, R.; DIPRETA, A. M.; RAGGI,
M. A. Determination of thiol drugs in pharmaceutical for-
mulations using ethacrynic-acid as a precolumn ultraviolet
derivatizaon reagent. Chromatographia , v. 23, n. 9, p.
-683, 1987.
CAVRINI, V.; GATTI, R.; ANDRISANO, V.; GATTI,
R. 1,1’-[ethenylidenebis (sulfonyl)] bis-benzene: A useful
pre-cromatographic derivatization reagent for HPLC analy-
ses of thiol drugs. Chromatographia , v. 42, n. 9-10, p.
-520, 1996.
DAVIS, R.; RIBNER, H.; KEUNG, E.; SONNENBLICK,
E.; LE-JEMTEL, T. Treatment of chronic congestive
heart-failure with captopril, and oral inhibitor of angio-
tensin converting enzyme. New England J. Med., v. 301,
n. 3, p. 117-121, 1979.
EL-ASHRY, S. M.; IBRAHIM, F. A. Colorimetric de-
termination of captopril in dosage forms. Anal. Lett., v.
, n. 9, p. 1657-1672, 1992.
EL-BRASHY, A. M. Titrimetric determination of
captopril in dosage forms. Acta Pharm. Hung., v. 65, n. 3,
p. 91-93, 1995.
FAVARO, G.; FIORANI, M. Determination of pharma-
ceutical thiols by chromatography with electrochemical
detection: use of an electrode with conductive carbon ce-
ment matrix, chemically modified with cobalt phthalocya-
nine. Anal. Chim. Acta, v. 332, n. 2-3, p. 249-255, 1996.
FRAGA, J. H. G.; ABIZANDA, A. I. J.; MORENO,
F.J.; LEON, J. J. A. Application of principal component
regression to the determination of captopril by differential
pulse polarography with no prior removal of dissolved
oxygen. Talanta, v. 46, n. 1, p. 75-82, 1998.
FIORY, K. Analytical profiles of drugs substances.
New York: Academic Press, 1982, v. 11. 81 p.
GUERRERO, R. S.; VIVES, S. S.; CALATAYUD, J. M.
Fluorometric determination of captopril by flow injection
analysis. Microchem. J., v. 43, p. 176-180, 1991.
HILLAERT, S.; VAN DEN BOSSCHE, W. Determina-
tion of captopril and its degradation products by capillary
electrophoresis. J. Pharm. Biomed. Anal., v. 21, n. 1, p.
-73, 1999.
JOVANIVIC, T.; STANOVIC, B.; KORICANAC, Z. Spectrophotometric investigation on complex-formation
of captopril with palladium (II) and its analytical applica-
tion. J. Pharm. Biomed. Anal., v. 13, n. 3, p. 213-217,
KOCH-WESTER, J. Angiotensin converting-enzyme
inhibitor in refractory hypertension. New England J. Med.,
v. 299, p. 363-364, 1978.
LEITE, F. Validação em análise química. 3a ed.
Campinas: Editora Átomo, 1998.p. 68.
MOHAMED, M. E.; ABOUL – ENEIN, H. Y.; GAD-
KARIEM, E. A. Potentiometric and visual titrimetric meth-
ods for analysis of captopril and its pharmaceutical forms.
Anal. Lett., v. 16, n. B1, p. 45-55, 1983.
MOHAMED, M. E.; ABOUL – ENEIN, H. Y.
Amperometric and conductimetric method for simulta-
neous determination of captopril and bendroflumethiazide.
Anal. Lett., v. 18, n. B20, p. 2591-2603, 1985.
NIKOLIC, K.; VALASEVIC, K. S. Conductometric
determination of captopril. Phamazie, v. 44, n. 2, p. 155-
, 1989.
NIKOLIC, K.; VALASEVIC, K. S. Coulometric deter-
mination of captopril. Acta Pol. Pharm., v. 48, n. 1-2, p.
-7, 1991.
PALOMEQUE, M. E.; BAND, B. S. F. Flow injection
biamperometric determination of captopril. J. Pharm.
Biomed. Anal., v. 30, n. 3, p. 547-552, 2002.
SANGHAVI, N. M.; SAMARTH, M. M.; MATHARU,
R.; SINGH, P. S. Colorimetric estimation of captopril and
its formulations. Indian Drugs, v. 28, n. 4, p. 189-191,
SARNA, K.; FIJALEK, Z. Voltammetric and electro-
chemical quartz crystal microbalance study of antithyroid
drugs. Chem. Anal., v. 42, n. 3, p. 425-433, 1997.
SASTRY, C. S. P.; SAILAJA, A.; RAO, T. T. Determi-
nation of captopril by two simple spectrophotometric
methods using oxidative coupling reaction. Pharmazie, v.
, n. 6, p. 465-457, 1991.
SKOOG, D. A.; WEST, D. M.; HOLLER, F. J. Funda-
mentals of analytical chemistry. 6th ed. Chicago: Saunders
College Publishing,1996. 849 p.
STEFAN R. I.; VAN STADEN, J. F.; ABOUL – ENEIN,
H. Y. A new construction for a potentiometric,
enantioselective membrane electrode – its utilization to
the S-captopril assay. Talanta, v. 48, n. 5, p. 1139-1143,
UNITED STATES PHARMACOPEIAL CONVENTION. The United States pharmacopeia: the national for-
mulary: captopril. 24th ed. Rockville, 2000. p. 296-298.
ZHANG, Z. D.; BAEJENS, W. R. G.; ZHANG, X. R.;
VAN DER WAKEN, T. Chemiluminescense flow injection
analysis of captopril applying a sensitized rhodamine 6G
method. J. Pharm. Biomed. Anal., v. 14, n. 8-10, p. 939-
, 1996.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2018 Eclética Química Journal